Siemens Healthineers upgrades mid-term guidance

Germany-based Siemens Healthineers is now expecting revenue growth of 6-8 percent in the period 2023-2025, up from its prior 5-percent estimate. Morever, the projection for earnings per share in this period is also raised, going from 10 percent to 15 percent.
Photo: Daniel Karmann/AP/Ritzau Scanpix
Photo: Daniel Karmann/AP/Ritzau Scanpix
by marketwire, translated by daniel pedersen

Siemens Healthineers, which sells products and solutions for the prevention, diagnosing, treatment and monitoring of diseases, has upgraded its mid-term guidance, Bloomberg News reports ahead of the company's capital markets day, referring to a press release.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading